A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

被引：0
|
作者：
George Fountzilas
Anna Fragkoulidi
Anna Kalogera-Fountzila
Martha Nikolaidou
Mattheos Bobos
Julien Calderaro
Felipe Andreiuolo
Marios Marselos
机构：
[1] Aristotle University of Thessaloniki School of Medicine,Department of Medical Oncology, “Papageorgiou” Hospital
[2] Aristotle University of Thessaloniki School of Medicine,Department of Radiology, AHEPA Hospital
[3] University of Ioannina School of Medicine,Department of Pharmacology
[4] Aristotle University of Thessaloniki School of Medicine,Department of Pathology
[5] Institut de Cancerologie Gustave Roussy,Translational Research Laboratory
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 65卷
关键词：
Head and neck cancer; Pharmacokinetic analysis; Sunitinib; Angiogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 660
页数：11
相关论文
共 50 条
  • [21] A phase II study of BAY 43-9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC).
    Siu, LL
    Winquist, E
    Agulnik, M
    Chin, SF
    Pond, GR
    Cheiken, R
    Francis, P
    Petrenciuc, O
    Chen, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 516S - 516S
  • [22] Phase II study of oral S-1 in pretreated patients with recurrent or metastatic head and neck cancer
    Park, S.
    Lee, S.
    Park, J.
    Cho, E.
    Shin, D.
    Lee, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Final results of a phase II study of erlotinib, docetaxel and cisplatin in patients with recurrent/metastatic head and neck cancer
    Kim, E. S.
    Kies, M. S.
    Glisson, B. S.
    Tsao, A.
    Ginsberg, L. E.
    Holsinger, F. C.
    Burke, B. J.
    Truong, M.
    Papadimitrakopoulou, A.
    Lippman, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01
    Machiels, Jean-Pascal H.
    Henry, Stephanie
    Zanetta, Sylvie
    Kaminsky, Marie-Christine
    Michoux, Nicolas
    Rommel, Denis
    Schmitz, Sandra
    Bompas, Emmanuelle
    Dillies, Anne-Francoise
    Faivre, Sandrine
    Moxhon, Anne
    Duprez, Thierry
    Guigay, Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 21 - 28
  • [25] Weekly chemotherapy with cisplatin and docetaxel for recurrent metastatic head and neck cancer: a phase II study
    Guntinas-Lichius, O.
    Appenrodt, S.
    Veelken, F.
    Krug, B.
    EJC SUPPLEMENTS, 2005, 3 (02): : 297 - 297
  • [26] A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer
    Basaran, M
    Bavbek, SE
    Güllü, I
    Demirelli, F
    Sakar, B
    Tenekeci, N
    Altun, M
    Yalçin, S
    Onat, H
    JOURNAL OF CHEMOTHERAPY, 2002, 14 (02) : 207 - 213
  • [27] Phase II Study of Sunitinib in Patients With Metastatic Urothelial Cancer
    Gallagher, David J.
    Milowsky, Matthew I.
    Gerst, Scott R.
    Ishill, Nicole
    Riches, Jamie
    Regazzi, Ashley
    Boyle, Mary G.
    Trout, Alisa
    Flaherty, Anne-Marie
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) : 1373 - 1379
  • [28] A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
    Lee, Ji Hyun
    Heo, Seong Gu
    Ahn, Beung-Chul
    Hong, Min Hee
    Cho, Byoung Chul
    Lim, Sun Min
    Kim, Hye Ryun
    CANCER MEDICINE, 2021, 10 (20): : 7012 - 7020
  • [29] A Phase II study of Sorafenib (BAY 43-9006) in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC)
    Chen, E.
    Winquist, E.
    Agulnik, M.
    Chin, S.
    Pond, G.
    Cheiken, R.
    Francis, P.
    Petrenciuc, O.
    Siu, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 297 - 297
  • [30] Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer
    Haigentz, Missak, Jr.
    Kim, Mimi
    Sarta, Catherine
    Lin, Juan
    Keresztes, Roger S.
    Culliney, Bruce
    Gaba, Anu G.
    Smith, Richard V.
    Shapiro, Geoffrey I.
    Chirieac, Lucian R.
    Mariadason, John M.
    Belbin, Thomas J.
    Greally, John M.
    Wright, John J.
    Haddad, Robert I.
    ORAL ONCOLOGY, 2012, 48 (12) : 1281 - 1288
12345